{"transactions":[{"id":1164921,"issuer":{"id":7177,"kind":"organization","name":"Instil Bio, Inc."},"owners":[{"id":80448,"kind":"person","name":"Crouch Bronson","position":1,"cik":"0001851041","reported_name":"Crouch Bronson","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"CEO and Chairman"}}],"security":"Employee Stock Option (right to buy)","published_at":"2025-04-28T17:00:15.000Z","date":"2025-04-25","kind":"grant","planned":false,"acquired":true,"shares":105157,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Twenty-five percent (25%) of the shares subject to the option vest on April 25, 2026, and the remaining shares subject to the option shall vest in thirty-six (36) equal monthly installments thereafter, subject to the Reporting Person continuing to provide service through each such date."}],"balance_after":105157,"derivative":{"exercise_price":12.78,"expiration_date":"2035-04-24","underlying":"Common Stock","underlying_shares":105157},"source":{"system":"sec-edgar","filing":"0001789769-25-000040","document":"wk-form4_1745874009.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1851041/000178976925000040/wk-form4_1745874009.xml","form_type":"4"}},{"id":1400955,"issuer":{"id":7177,"kind":"organization","name":"Instil Bio, Inc."},"owners":[{"id":80448,"kind":"person","name":"Crouch Bronson","position":1,"cik":"0001851041","reported_name":"Crouch Bronson","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"CEO and Chairman"}}],"security":"Employee Stock Option (right to buy)","published_at":"2024-09-23T13:07:52.000Z","date":"2024-09-18","kind":"grant","planned":false,"acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Twenty-five percent (25%) of the shares subject to the option vest on September 18, 2025, and the remaining shares subject to the option shall vest in thirty-six (36) equal monthly installments thereafter, subject to the Reporting Person continuing to provide service through each such date."}],"balance_after":50000,"derivative":{"exercise_price":66.1,"expiration_date":"2034-09-17","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001789769-24-000093","document":"wk-form4_1727111266.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1851041/000178976924000093/wk-form4_1727111266.xml","form_type":"4"}},{"id":1646496,"issuer":{"id":7177,"kind":"organization","name":"Instil Bio, Inc."},"owners":[{"id":80448,"kind":"person","name":"Crouch Bronson","position":1,"cik":"0001851041","reported_name":"Crouch Bronson","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"CEO and Chairman"}}],"security":"Employee Stock Option (right to buy)","published_at":"2024-02-13T17:36:52.000Z","date":"2024-02-10","kind":"grant","planned":false,"acquired":true,"shares":120000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Twenty-five percent (25%) of the shares subject to the option vest on February 10, 2025, and the remaining shares subject to the option shall vest in thirty-six (36) equal monthly installments thereafter, subject to the Reporting Person continuing to provide service through each such date."}],"balance_after":120000,"derivative":{"exercise_price":11.6,"expiration_date":"2034-02-09","underlying":"Common Stock","underlying_shares":120000},"source":{"system":"sec-edgar","filing":"0001789769-24-000023","document":"wk-form4_1707863794.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1851041/000178976924000023/wk-form4_1707863794.xml","form_type":"4"}},{"id":2049835,"issuer":{"id":7177,"kind":"organization","name":"Instil Bio, Inc."},"owners":[{"id":80448,"kind":"person","name":"Crouch Bronson","position":1,"cik":"0001851041","reported_name":"Crouch Bronson","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"CEO and Chairman"}}],"security":"Employee Stock Option (right to buy)","published_at":"2023-01-20T16:11:58.000Z","date":"2022-03-04","kind":"grant","acquired":true,"shares":750000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Twenty-five percent (25%) of the shares subject to the option vest on March 4, 2023, and the remaining shares subject to the option shall vest in thirty-six (36) equal monthly installments thereafter, subject to the Reporting Person continuing to provide service through each such date."}],"balance_after":750000,"derivative":{"exercise_price":8.62,"expiration_date":"2032-03-03","underlying":"Common Stock","underlying_shares":750000},"source":{"system":"sec-edgar","filing":"0001789769-23-000014","document":"wf-form4a_167424910228120.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1851041/000178976923000014/wf-form4a_167424910228120.xml","form_type":"4/A","original_submission_date":"2022-03-07"}},{"id":2049834,"issuer":{"id":7177,"kind":"organization","name":"Instil Bio, Inc."},"owners":[{"id":80448,"kind":"person","name":"Crouch Bronson","position":1,"cik":"0001851041","reported_name":"Crouch Bronson","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"CEO and Chairman"}}],"security":"Employee Stock Option (right to buy)","published_at":"2023-01-20T16:09:25.000Z","date":"2023-01-08","kind":"grant","acquired":true,"shares":1000000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Twenty-five percent (25%) of the shares subject to the option vest on January 8, 2024, and the remaining shares subject to the option shall vest in thirty-six (36) equal monthly installments thereafter, subject to the Reporting Person continuing to provide service through each such date."}],"balance_after":1000000,"derivative":{"exercise_price":0.634,"expiration_date":"2033-01-07","underlying":"Common Stock","underlying_shares":1000000},"source":{"system":"sec-edgar","filing":"0001789769-23-000010","document":"wf-form4_167424895139494.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1851041/000178976923000010/wf-form4_167424895139494.xml","form_type":"4"}},{"id":2348213,"issuer":{"id":7177,"kind":"organization","name":"Instil Bio, Inc."},"owners":[{"id":80448,"kind":"person","name":"Crouch Bronson","position":1,"cik":"0001851041","reported_name":"Crouch Bronson","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"CEO and Chairman"}}],"security":"Employee Stock Option (right to buy)","published_at":"2022-03-07T17:08:31.000Z","date":"2022-03-04","kind":"grant","acquired":true,"shares":750000,"price":8.62,"value":6465000.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Twenty-five percent (25%) of the shares subject to the option vest on March 4, 2023, and the remaining shares subject to the option shall vest in thirty-six (36) equal monthly installments thereafter, subject to the Reporting Person continuing to provide service through each such date."}],"balance_after":750000,"derivative":{"exercise_price":8.62,"expiration_date":"2032-03-03","underlying":"Common Stock","underlying_shares":750000},"source":{"system":"sec-edgar","filing":"0001789769-22-000014","document":"wf-form4_164669088804336.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1851041/000178976922000014/wf-form4_164669088804336.xml","form_type":"4"}},{"id":2714692,"issuer":{"id":7177,"kind":"organization","name":"Instil Bio, Inc."},"owners":[{"id":80448,"kind":"person","name":"Crouch Bronson","position":1,"cik":"0001851041","reported_name":"Crouch Bronson","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"CEO and Chairman"}}],"security":"Employee Stock Option (right to buy)","published_at":"2021-05-13T16:51:55.000Z","date":"2021-05-11","kind":"grant","acquired":true,"shares":750000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in forty-eight (48) equal monthly installments commencing on June 11, 2021, subject to the Reporting Person continuing to provide service through each such date"}],"balance_after":750000,"derivative":{"exercise_price":16.25,"expiration_date":"2031-05-10","underlying":"Common Stock","underlying_shares":750000},"source":{"system":"sec-edgar","filing":"0001789769-21-000034","document":"wf-form4_162093909524987.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1851041/000178976921000034/wf-form4_162093909524987.xml","form_type":"4"}},{"id":2772200,"issuer":{"id":7177,"kind":"organization","name":"Instil Bio, Inc."},"owners":[{"id":80448,"kind":"person","name":"Crouch Bronson","position":1,"cik":"0001851041","reported_name":"Crouch Bronson","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"CEO and Chairman"}}],"security":"Series C Preferred Stock","published_at":"2021-03-25T16:27:15.000Z","date":"2021-03-23","kind":"exercise","acquired":false,"shares":1192729,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of Series A Preferred Stock, Series B Preferred Stock and Series C Preferred Stock automatically converted into shares of Common Stock upon the closing of the Issuer's initial public offering for no additional consideration, on a 1.2 for one basis, and had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each share of Series A Preferred Stock, Series B Preferred Stock and Series C Preferred Stock automatically converted into shares of Common Stock upon the closing of the Issuer's initial public offering for no additional consideration, on a 1.2 for one basis, and had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each share of Series A Preferred Stock, Series B Preferred Stock and Series C Preferred Stock automatically converted into shares of Common Stock upon the closing of the Issuer's initial public offering for no additional consideration, on a 1.2 for one basis, and had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The securities are held by Curative Ventures V LLC (the \"LLC\"). CV-Immetacyte Ultimate Manager LLC (\"Ultimate Manager\") is the general\npartner of CV-Immetacyte Manager LP, the general partner of the LLC. The Reporting Person is the manager of Ultimate Manager and disclaims\nSection 16 beneficial ownership of such securities except to the extent of his pecuniary interest therein."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":1431274},"source":{"system":"sec-edgar","filing":"0001209191-21-023006","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1851041/000120919121023006/doc4.xml","form_type":"4"}},{"id":2772199,"issuer":{"id":7177,"kind":"organization","name":"Instil Bio, Inc."},"owners":[{"id":80448,"kind":"person","name":"Crouch Bronson","position":1,"cik":"0001851041","reported_name":"Crouch Bronson","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"CEO and Chairman"}}],"security":"Series B Preferred Stock","published_at":"2021-03-25T16:27:15.000Z","date":"2021-03-23","kind":"exercise","acquired":false,"shares":5082333,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of Series A Preferred Stock, Series B Preferred Stock and Series C Preferred Stock automatically converted into shares of Common Stock upon the closing of the Issuer's initial public offering for no additional consideration, on a 1.2 for one basis, and had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each share of Series A Preferred Stock, Series B Preferred Stock and Series C Preferred Stock automatically converted into shares of Common Stock upon the closing of the Issuer's initial public offering for no additional consideration, on a 1.2 for one basis, and had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each share of Series A Preferred Stock, Series B Preferred Stock and Series C Preferred Stock automatically converted into shares of Common Stock upon the closing of the Issuer's initial public offering for no additional consideration, on a 1.2 for one basis, and had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The securities are held by Curative Ventures V LLC (the \"LLC\"). CV-Immetacyte Ultimate Manager LLC (\"Ultimate Manager\") is the general\npartner of CV-Immetacyte Manager LP, the general partner of the LLC. The Reporting Person is the manager of Ultimate Manager and disclaims\nSection 16 beneficial ownership of such securities except to the extent of his pecuniary interest therein."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":6098799},"source":{"system":"sec-edgar","filing":"0001209191-21-023006","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1851041/000120919121023006/doc4.xml","form_type":"4"}},{"id":2772198,"issuer":{"id":7177,"kind":"organization","name":"Instil Bio, Inc."},"owners":[{"id":80448,"kind":"person","name":"Crouch Bronson","position":1,"cik":"0001851041","reported_name":"Crouch Bronson","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"CEO and Chairman"}}],"security":"Series A Preferred Stock","published_at":"2021-03-25T16:27:15.000Z","date":"2021-03-23","kind":"exercise","acquired":false,"shares":25000000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of Series A Preferred Stock, Series B Preferred Stock and Series C Preferred Stock automatically converted into shares of Common Stock upon the closing of the Issuer's initial public offering for no additional consideration, on a 1.2 for one basis, and had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each share of Series A Preferred Stock, Series B Preferred Stock and Series C Preferred Stock automatically converted into shares of Common Stock upon the closing of the Issuer's initial public offering for no additional consideration, on a 1.2 for one basis, and had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each share of Series A Preferred Stock, Series B Preferred Stock and Series C Preferred Stock automatically converted into shares of Common Stock upon the closing of the Issuer's initial public offering for no additional consideration, on a 1.2 for one basis, and had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The securities are held by Curative Ventures V LLC (the \"LLC\"). CV-Immetacyte Ultimate Manager LLC (\"Ultimate Manager\") is the general\npartner of CV-Immetacyte Manager LP, the general partner of the LLC. The Reporting Person is the manager of Ultimate Manager and disclaims\nSection 16 beneficial ownership of such securities except to the extent of his pecuniary interest therein."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":30000000},"source":{"system":"sec-edgar","filing":"0001209191-21-023006","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1851041/000120919121023006/doc4.xml","form_type":"4"}},{"id":2772197,"issuer":{"id":7177,"kind":"organization","name":"Instil Bio, Inc."},"owners":[{"id":80448,"kind":"person","name":"Crouch Bronson","position":1,"cik":"0001851041","reported_name":"Crouch Bronson","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"CEO and Chairman"}}],"security":"Common Stock","published_at":"2021-03-25T16:27:15.000Z","date":"2021-03-23","kind":"purchase","acquired":true,"shares":450000,"price":20,"value":9000000.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The securities are held by Curative Ventures V LLC (the \"LLC\"). CV-Immetacyte Ultimate Manager LLC (\"Ultimate Manager\") is the general\npartner of CV-Immetacyte Manager LP, the general partner of the LLC. The Reporting Person is the manager of Ultimate Manager and disclaims\nSection 16 beneficial ownership of such securities except to the extent of his pecuniary interest therein."}],"balance_after":37980073,"source":{"system":"sec-edgar","filing":"0001209191-21-023006","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1851041/000120919121023006/doc4.xml","form_type":"4"}},{"id":2772196,"issuer":{"id":7177,"kind":"organization","name":"Instil Bio, Inc."},"owners":[{"id":80448,"kind":"person","name":"Crouch Bronson","position":1,"cik":"0001851041","reported_name":"Crouch Bronson","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"CEO and Chairman"}}],"security":"Common Stock","published_at":"2021-03-25T16:27:15.000Z","date":"2021-03-23","kind":"exercise","acquired":true,"shares":1431274,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of Series A Preferred Stock, Series B Preferred Stock and Series C Preferred Stock automatically converted into shares of Common Stock upon the closing of the Issuer's initial public offering for no additional consideration, on a 1.2 for one basis, and had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The securities are held by Curative Ventures V LLC (the \"LLC\"). CV-Immetacyte Ultimate Manager LLC (\"Ultimate Manager\") is the general\npartner of CV-Immetacyte Manager LP, the general partner of the LLC. The Reporting Person is the manager of Ultimate Manager and disclaims\nSection 16 beneficial ownership of such securities except to the extent of his pecuniary interest therein."}],"balance_after":37530073,"source":{"system":"sec-edgar","filing":"0001209191-21-023006","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1851041/000120919121023006/doc4.xml","form_type":"4"}},{"id":2772195,"issuer":{"id":7177,"kind":"organization","name":"Instil Bio, Inc."},"owners":[{"id":80448,"kind":"person","name":"Crouch Bronson","position":1,"cik":"0001851041","reported_name":"Crouch Bronson","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"CEO and Chairman"}}],"security":"Common Stock","published_at":"2021-03-25T16:27:15.000Z","date":"2021-03-23","kind":"exercise","acquired":true,"shares":6098799,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of Series A Preferred Stock, Series B Preferred Stock and Series C Preferred Stock automatically converted into shares of Common Stock upon the closing of the Issuer's initial public offering for no additional consideration, on a 1.2 for one basis, and had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The securities are held by Curative Ventures V LLC (the \"LLC\"). CV-Immetacyte Ultimate Manager LLC (\"Ultimate Manager\") is the general\npartner of CV-Immetacyte Manager LP, the general partner of the LLC. The Reporting Person is the manager of Ultimate Manager and disclaims\nSection 16 beneficial ownership of such securities except to the extent of his pecuniary interest therein."}],"balance_after":36098799,"source":{"system":"sec-edgar","filing":"0001209191-21-023006","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1851041/000120919121023006/doc4.xml","form_type":"4"}},{"id":2772194,"issuer":{"id":7177,"kind":"organization","name":"Instil Bio, Inc."},"owners":[{"id":80448,"kind":"person","name":"Crouch Bronson","position":1,"cik":"0001851041","reported_name":"Crouch Bronson","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"CEO and Chairman"}}],"security":"Common Stock","published_at":"2021-03-25T16:27:15.000Z","date":"2021-03-23","kind":"exercise","acquired":true,"shares":30000000,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of Series A Preferred Stock, Series B Preferred Stock and Series C Preferred Stock automatically converted into shares of Common Stock upon the closing of the Issuer's initial public offering for no additional consideration, on a 1.2 for one basis, and had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The securities are held by Curative Ventures V LLC (the \"LLC\"). CV-Immetacyte Ultimate Manager LLC (\"Ultimate Manager\") is the general\npartner of CV-Immetacyte Manager LP, the general partner of the LLC. The Reporting Person is the manager of Ultimate Manager and disclaims\nSection 16 beneficial ownership of such securities except to the extent of his pecuniary interest therein."}],"balance_after":30000000,"source":{"system":"sec-edgar","filing":"0001209191-21-023006","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1851041/000120919121023006/doc4.xml","form_type":"4"}},{"id":2776423,"issuer":{"id":7177,"kind":"organization","name":"Instil Bio, Inc."},"owners":[{"id":80448,"kind":"person","name":"Crouch Bronson","position":1,"cik":"0001851041","reported_name":"Crouch Bronson","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"CEO and Chairman"}}],"security":"Employee Stock Option (right to buy)","published_at":"2021-03-22T20:50:42.000Z","date":"2021-03-18","kind":"grant","acquired":true,"shares":1200000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in forty-eight (48) equal monthly installments commencing on March 19, 2021, subject to the Reporting Person continuing to provide service through each such\ndate."}],"balance_after":1200000,"derivative":{"exercise_price":5.95,"expiration_date":"2031-02-09","underlying":"Common Stock","underlying_shares":1200000},"source":{"system":"sec-edgar","filing":"0001209191-21-022472","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1851041/000120919121022472/doc4.xml","form_type":"4"}}]}